Raymond James Financial Services Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-32,400
Closed -$8K 3416
2021
Q4
$8K Hold
32,400
﹤0.01% 3276
2021
Q3
$45K Buy
32,400
+1,800
+6% +$137K ﹤0.01% 3194
2021
Q2
$81K Sell
30,600
-24,525
-44% -$1.82M ﹤0.01% 3167
2021
Q1
$43K Buy
55,125
+3,249
+6% +$240K ﹤0.01% 3106
2020
Q4
$48K Buy
+51,876
New +$3.97M ﹤0.01% 2916
2020
Q1
Sell
-16,978
Closed -$20K 2698
2019
Q4
$20K Buy
+16,978
New +$1.39M ﹤0.01% 2803

Other funds holding MRK

Raymond James Financial Services Advisors's MRK Position: Q3 2024 in Review

Raymond James Financial Services Advisors reduced its Merck (MRK) stake by 0.85% in Q3 2024, selling an estimated $3.67M and leaving 3,603,148 shares worth $409M. The position accounts for 0.55% of the portfolio, ranked #33.

Raymond James Financial Services Advisors first reported a position in MRK in Q2 2013 and has held it in 45 quarters since. The position peaked at $472M in Q1 2024. 3,491 funds tracked by Wall St. Rank hold MRK as of Q3 2024.

  • Raymond James Financial Services Advisors held 3,603,148 shares of Merck worth $409M as of Q3 2024.
  • Raymond James Financial Services Advisors sold 30,866 Merck shares in Q3 2024, an estimated $3.67M.
  • Merck made up 0.55% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #33 holding.
  • Raymond James Financial Services Advisors first reported a position in Merck in Q2 2013 and has held it in 45 quarters since.
  • Raymond James Financial Services Advisors's Merck position peaked at $472M in Q1 2024.
  • 3,491 funds tracked by Wall St. Rank held Merck as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.